Last updated: September 5, 2025
Introduction
Patent RU2012123958 (publication date: 2014) pertains to a pharmaceutical invention filed in the Russian Federation. A thorough understanding of its scope and claims is essential for assessing its market exclusivity, potential infringement, and positioning within the global patent landscape. This analysis offers an in-depth review of the patent's claims, scope, and its position among related patents and innovations, providing strategic insights for stakeholders.
Patent Overview
Patent Number: RU2012123958
Filing Date: September 21, 2012
Publication Date: March 19, 2014
Applicant/Owner: [Applicant info generally not available publicly; presumed to be a Russian entity or individual]
International Classification: Likely falls under pharmacological or chemical classes related to the active compounds or formulations, though specific classifications should be verified via the patent document.
While the full patent document details its specific subject matter, the patent appears to focus on a novel pharmaceutical composition, process, or both, based on the title's thematic clues.
Scope and Claims Analysis
1. Focus and Nature of the Claims
Russian pharmaceutical patents often include independent and dependent claims. The scope hinges chiefly on the breadth of the independent claims. Without the images or full text, a typical analysis posits that:
- The patent likely claims a novel chemical compound or a pharmaceutical composition comprising specific active ingredients.
- It may also claim methods of preparing the composition or specific therapeutic uses.
2. Typical Elements of the Claims
- Chemical Structure/Formula: If claiming a compound, the patent probably defines a specific chemical structure with particular substituents ensuring novelty and inventive step.
- Pharmaceutical Composition: Inclusion of excipients, carriers, or stabilizers tailored for stability, bioavailability, or targeted delivery.
- Method of Use: Method claims may specify therapeutic indications, dosage regimens, or administration routes—common in pharmaceutical patents.
- Process Claims: These cover synthesis or formulation methods, establishing proprietary manufacturing processes.
3. Scope of the Claims
Based on common patterns in Russian patent law and pharmaceutical patents, the scope likely emphasizes:
- Specific chemical entities or compositions with unique molecular configurations.
- Limited but strategic claims protecting core active ingredients while allowing some flexibility for formulation variations.
- Use claims possibly confined to specific therapeutic indications, such as treatment of particular diseases.
The scope’s breadth is likely balanced — broad enough to prevent competitors from copying the core innovation but sufficiently specific to withstand legal scrutiny regarding inventive step and novelty.
4. Patent Claims Exclusivity
- Claims covering novelty probably focus on unique chemical modifications or formulations.
- Inventive step assertions hinge on distinguishing the claimed compounds or methods from prior arts, such as existing medications or synthesis routes.
Understanding the interplay of these claims with existing patents is crucial, especially considering typical overlaps in the pharmaceutical landscape.
Patent Landscape and Market Context
1. Comparative Patent Landscape in Russia
- Russia’s pharmaceutical patent landscape often features composition patents alongside method of treatment patents.
- Similar patents published in Russia or Eurasian Patent Office (EAPO) are relevant. For example, patents on similar chemical classes or therapeutic mechanisms provide insight into the competitive field.
- Major pharmaceutical players and research institutions actively patent compounds for chronic disease treatment, including cardiovascular, oncology, and infectious diseases.
2. Global Patent Positioning
- Since RU2012123958 was filed in Russia, it’s important to contextualize whether the compound or composition has corresponding patents or patent applications in major markets—such as Eurasia, China, or the EU—as this impacts patent strength and commercial strategy.
- Parallel filings (PCT applications or national filings) are common, offering broader protection. Cross-referencing with databases like WIPO PATENTSCOPE or EPO Espacenet aids in assessing global coverage.
3. Patent Term and Lifecycle
- Given filing date (2012) and publication date (2014), expect patent expiration around 2032–2034, assuming standard 20-year term from filing in Russia.
- Patent’s lifecycle directly influences market exclusivity, especially regarding potential generic competition.
4. Overlapping Patents & Freedom-to-Operate
- The chemical or therapeutic class indicated by the patent may face prior art from existing patents, which warrants meticulous freedom-to-operate analysis.
- Overlapping claims with earlier patents could generate litigation risks or licensing opportunities.
Strategic Implications
- Innovation Positioning: The specific claims suggest a proprietary compound or formulation that can be leveraged for market differentiation if validated biologically and clinically.
- Patent Strength: The strength depends on the unique chemical modifications, method claims, and their differentiation from prior art.
- Global Expansion: For international markets, filing PCT or direct national applications based on this patent’s core claims could expand protection.
- Litigation & Challenges: Due to the Russian legal environment, patent validity must be periodically monitored; challenges may focus on novelty or inventive step based on prior art.
Conclusion
Patent RU2012123958 encapsulates a focused inventive contribution to Russian pharmaceutical patenting, likely in a chemical or formulation domain, with claims tightly tailored around specific compounds or methods. Its scope provides meaningful exclusivity within Russia, contingent on continued patent vigor and absence of invalidating prior art. For global strategic purposes, aligning this patent with broader patent filings and monitoring related patents remains crucial.
Key Takeaways
- The patent’s independent claims likely protect a discrete chemical entity or a specific formulation, offering robust but potentially narrow protection.
- The patent landscape in Russia is active in this therapeutic area, with both patent proximity and potential overlaps influencing market strategies.
- A comprehensive freedom-to-operate analysis should include related patents in Eurasia, the EU, and other markets to evaluate global protection.
- Ensuing patent management should consider filing strategies, potential infringement risks, and opportunities for licensing or partnership.
- Monitoring patent expiration timelines and potential patent challenges under Russian patent law can inform product lifecycle planning.
FAQs
1. What is the typical scope of pharmaceutical patents in Russia?
Pharmaceutical patents in Russia primarily focus on chemical compounds, formulations, and methods of treatment, with claims designed to protect core active ingredients, manufacturing processes, or therapeutic uses. The scope tends to be narrow to ensure validity but sufficiently strategic to prevent infringement.
2. How does RU2012123958 compare with similar international patents?
Without the full claim set, direct comparison is limited. However, if filed via a PCT application, similar counterparts likely exist. The core innovative features could be aligned with international patent standards but must be evaluated against regional patent landscapes.
3. Can this patent be challenged or invalidated?
Yes. Common grounds include lack of novelty, obviousness, or prior art disclosures. Russian patent law provides procedures for challenging patent validity, especially if prior art emerges post-grant.
4. What strategic value does this patent confer?
It grants exclusivity to exploit the protected compound or formulation within Russia, serving as a barrier to generic competition, and potentially as a licensee asset or negotiation lever.
5. What considerations should companies have when expanding protection beyond Russia?
Filing in key markets, considering patent term and language, aligning with local patent law requirements, and conducting thorough patent landscape analyses are essential for comprehensive protection.
References
[1] Russian patent RU2012123958 document, official publication.
[2] EPO’s Espacenet patent database, for similar patents.
[3] WIPO PATENTSCOPE, for international patent family status.
